Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

BLX 1002

Known as: BLX-1002, BLX1002 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
BLX‐1002 is a novel thiazolidinedione with no peroxisome proliferator‐activated receptor (PPAR) activity that has been shown to… Expand
2012
2012
BackgroundThe leading cause of death for patients suffering from diabetes is macrovascular disease. Endothelial dysfunction is… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2011
2011
The pharmacology of thiazolidinediones (TZDs) seems to be driven not only by activation of peroxisome proliferator-activated… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2009
2009
BLX-1002 is a novel small thiazolidinedione with no apparent affinity to peroxisome proliferator-activated receptors (PPAR) that… Expand
2007
2007
Procurando responder a tendencia emergente de avaliacao do desempenho dos organismos da Administracao Publica portuguesa, o… Expand
2007
2007
............................................................................................................................... 2… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 6
2003
2003
KOHCTPYKUM~ M Texnonorm M~~OTOB~~HMR ~~HT~KCM~~~H~IX re- Tepompytcryp Ann nonesbix cB%TpaH3MCTOpOB M nonynpo- BoAnmoebix nasepos… Expand
1984
1984
The objectives of the investigation \1. ere to examine the natural breeding and productivity of ewe hoggets in comparison with… Expand